Aviscera Spike Histag

Histag Antibody
K06246M11G09C-100ug 100 ug
EUR 280
Description: Monoclonal Antibody

Human IgG antibody Laboratories manufactures the aviscera spike histag reagents distributed by Genprice. The Aviscera Spike Histag reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike His. Other Aviscera products are available in stock. Specificity: Aviscera Category: Spike Group: Histag

Recombinant Human PARK2 protein, C-HisTag
0.05mg
EUR 320

Recombinant Human PARK2 protein, C-HisTag
0.1mg
EUR 410

Recombinant Human PARK2 protein, C-HisTag
5x0.1mg
EUR 1520

COVID-19 Spike RBD and Membrane Protein Human IgG ELISA Assay
48AntigenWells&48ControlAntigenWells
EUR 635

COVID-19 Spike RBD and Membrane Protein Human IgG ELISA Assay
5x48AntigenWells&5x48ControlAntigenWells
EUR 2900

Recombinant Human Oncostatin M protein, C-HisTag
0.05mg
EUR 345

Recombinant Human Oncostatin M protein, C-HisTag
0.1mg
EUR 450

Histag information

Spike Trimer (S1+S2), His-tag (SARS-CoV-2)
100728-1 100 µg
EUR 350
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), with 682RRAR685>A, K986P, and V987P mutations, Genbank Accession No. MN908947, a.a. 1-1213, with a C-terminal His-tag, expressed in a HEK293 expression system. MW=139 kDa.

Spike Trimer (S1+S2), His-tag (SARS-CoV-2)
100728-2 1 mg
EUR 2995
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), with 682RRAR685>A, K986P, and V987P mutations, Genbank Accession No. MN908947, a.a. 1-1213, with a C-terminal His-tag, expressed in a HEK293 expression system. MW=139 kDa.

Recombinant HCoV-OC43 Spike Protein, His-tagged
Spike-350V 100ug
EUR 1358.4
Description: Samples are stable for up to twelve months from date of receipt at -20°C to -80°C
Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Recombinant SARS Spike Mosaic Antigen, His-tagged
VAC-0281 0.5ml
EUR 798.4
Description: Protein

Recombinant SARS MERS Spike S1 Antigen, His-tagged
VAC-0277 0.5ml
EUR 798.4
Description: Protein

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)
P1540-10 10 µg
EUR 211.2

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)
P1540-50 50 µg
EUR 818.4

SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293)
REC31809-100 0.1
EUR 486.7
Description: Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography.

SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293)
REC31809-500 0.5
EUR 1854.09
Description: Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography.

MERS Coronavirus Spike Glycoprotein (S1), His-tag (E. coli)
REC31760-100 0.1
EUR 415.88
Description: A peptide from amino acids 56 to 295 of Spike protein S1 (Accession: AHC74088) was expressed and purified from E. coli, with a 6xHis tag is attached to its C-terminus.

MERS Coronavirus Spike Glycoprotein (S1), His-tag (E. coli)
REC31760-500 0.5
EUR 1560.53
Description: A peptide from amino acids 56 to 295 of Spike protein S1 (Accession: AHC74088) was expressed and purified from E. coli, with a 6xHis tag is attached to its C-terminus.

SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO)
REC31871-100 0.1
EUR 672.11
Description: Trimeric SARS-CoV-2 spike protein in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., 2020).

SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO)
REC31871-1000 0.5
EUR 4599.17
Description: Trimeric SARS-CoV-2 spike protein in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., 2020).

SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO)
REC31871-500 0.5
EUR 2554.52
Description: Trimeric SARS-CoV-2 spike protein in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., 2020).

Spike Trimer (S1+S2), His-tag, Eu-labeled (SARS-CoV-2)
100894 25 µg
EUR 295
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), Genbank Accession No. MN908947, a.a. 16-1213, with a with C-terminal His-tag, Eu-labeled, expressed in a HEK293 expression system. MW=139 kDa. This protein runs at a higher M.W. by SDS-PAGE due to glycosylation.

Spike Trimer (S1+S2) (P.1 Variant), His-Tag (SARS-CoV-2)
100989-1 100 µg
EUR 320
Description: Recombinant SARS-CoV-2 Spike protein in its homotrimeric form, containing S1+S2 subunits and encompassing amino acids 16-1213. This protein corresponds to SARS-CoV2 Variant P.1 originally discovered in Brazil and contains 11 mutations in addition to 682RRAR685>A, K986P and V987P, as listed below. The construct also contains a C-terminal His-tag. Note that the expected MW of the S1+S2 monomer is 136kDa but migrates at a higher MW in SDS-PAGE due to glycosylation. The recombinant protein is ≥90% pure following high affinity Ni-NTA purification.

Spike Trimer (S1+S2) (P.1 Variant), His-Tag (SARS-CoV-2)
100989-2 1 mg
EUR 2850
Description: Recombinant SARS-CoV-2 Spike protein in its homotrimeric form, containing S1+S2 subunits and encompassing amino acids 16-1213. This protein corresponds to SARS-CoV2 Variant P.1 originally discovered in Brazil and contains 11 mutations in addition to 682RRAR685>A, K986P and V987P, as listed below. The construct also contains a C-terminal His-tag. Note that the expected MW of the S1+S2 monomer is 136kDa but migrates at a higher MW in SDS-PAGE due to glycosylation. The recombinant protein is ≥90% pure following high affinity Ni-NTA purification.